Fahrtauglichkeit bei Parkinson-Erkrankung

Die Einschätzung der Fahrtauglichkeit bei Patienten mit Parkinson-Erkrankung ist im Praxisalltag wichtig, aber schwierig und wird oft sowohl von Patienten als auch Ärzten ungern thematisiert. Dieser Beitrag zeigt, welche medizinischen Aspekte eine verminderte Fahrkompetenz entweder als fehlende generelle Fahrtauglichkeit oder als temporär eingeschränkte Fahrfähigkeit anzeigen, welche juristischen Aspekte der Arzt berücksichtigen muss und schlägt ein praxisnahes Vorgehen zur Abklärung der Fahrkompetenz vor.

Schlüsselwörter

Morbus Parkinson - Auto fahren - Führerschein - Fahrtauglichkeit - Fahrfähigkeit - Kraftfahrzeug

Publication History

Article published online:
16 October 2024

• Literatur

• 1 Meindorfner C, Korner Y, Moller JC. et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005; 20: 832-842
• 2 Buhmann C, Vettorazzi E, Oehlwein C. et al. Impact of Deep Brain Stimulation on Daily Routine Driving Practice in Patients with Parkinson's Disease. Parkinsons Dis 2015;
• 3 Cordell R, Lee HC, Granger A. et al. Driving assessment in Parkinson’s disease – a novel predictor of performance?. Mov Disord 2008; 23: 1217-1222
• 4 Uc EY, Rizzo M, Johnson AM. et al. Road safety in drivers with Parkinson disease. Neurology 2009; 73: 2112-2119
• 5 Wood JM, Worringham C, Kerr G. et al. Quantitative assessment of driving performance in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2005; 76: 176-180
• 6 Crizzle AM, Classen S, Uc EY. Parkinson disease and driving: An evidence-based review. Neurology 2012; 79: 2067-2074
• 7 Gräcmann N, Albrecht M. Bundesanstalt für Straßenwesen (BASt). Begutachtungs-Leitlinien zur Kraftfahrereignung. Letzte Änderung am 2. November 2009. Carl Schünemann Verlag GmbH; 2010
• 8 Heikkila VM, Turkka J, Korpelainen J. et al. Decreased driving ability in people with Parkinson’s disease. J Neurol Neurosurg Psychiat 1998; 64: 325-330
• 9 Klimkeit EI, Bradshaw JL, Charlton J. et al. Driving ability in Parkinson’s disease: current status of research. Neurosci Biobehav Rev 2009; 33: 223-231
• 10 Buhmann C, Gerloff C. Autofahren bei Morbus Parkinson. Akt Neurol 2013; 40: 315-320
• 11 Mattern R, Körner Y, Wagenpfeil T. Fahrtüchtigkeit bei chronischen Erkrankungen – Ärzte in der Pflicht. Dtsch Med Wochenschr 2006; 131: 2200-2201
• 12 Berghaus G, Brenner-Hartmann J. Fahreignung, Fahrsicherheit und deren Begutachtung. In: Madea B, Mußhoff F, Berghaus G. Verkehrsmedizin: Fahreignung, Fahrsicherheit, Unfallrekonstruktion. Köln: Deutscher Ärzte-Verlag; 2012: 131-143
• 13 Gaidzik P. Ärztliche Beurteilung der Kraftfahreignung. In: Widder B, Gaidzik P. Begutachtungen in der Neurologie. Stuttgart: Georg Thieme Verlag; 2011: 258-259
• 14 Landesärztekammer Baden-Württemberg mit den Bezirksärztekammern. Merkblatt – Die Aufklärungspflichen des Arztes – Stand Februar 2016 (Zugriff am 31.10.2021). https://www.aerztekammer-bw.de/10aerzte/40merkblaetter/10merkblaetter/aufklaerungspflicht.pdf
• 15 Rauschelbach H-H, Jochheim K-A. Ärztliche Beurteilung der Kraftfahreignung. In: Widder B, Gaidzik PW. Begutachtung in der Neurologie. Stuttgart: Thieme; 2011: 258
• 16 Fries W, Netz J, Bötzel K. et al. Leitlinie zur Beurteilung der Fahreignung bei neurologischen Erkrankungen. Akt Neurol 2005; 32: 342-350
• 17 Singh R, Pentland B, Hunter J. et al. Parkinson’s disease and driving ability. J Neurol Neurosurg Psychiatry 2007; 78: 363-366
• 18 Dubinsky RM, Gray C, Husted D. et al. Driving in Parkinson’s disease. Neurology 1991; 41: 517-520
• 19 Worringham CJ, Wood JM, Kerr GK. et al. Predictors of driving assessment outcome in Parkinson’s disease. Mov Disord 2006; 21: 230-235
• 20 Uc EY, Rizzo M, Anderson SW. et al. Driving under low-contrast visibility conditions in Parkinson disease. Neurology 2009; 73: 1103-1110
• 21 Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 2016; 15: 1257-1272
• 22 Hirtz D, Thurman DJ, Gwinn-Hardy K. et al. How common are the „common“ neurologic disorders?. Neurology 2007; 68: 326-337
• 23 Uc EY, Rizzo M. Driving and neurodegenerative diseases. Curr Neurol Neurosci Rep 2008; 8: 377-383
• 24 Man-Son-Hing M, Marshall SC, Molnar FJ. et al. Systematic review of driving risk and the efficacy of compensatory strategies in persons with dementia. J Am Geriatr Soc 2007; 55: 878-884
• 25 Ranchet M, Broussolle E, Paire-Ficout L. Longitudinal executive changes in drivers with parkinson’s disease: study using neuropsychological and driving simulator tasks. Eur Neurol 2016; 76: 143-150
• 26 Devos H, Vandenberghe W, Tant M. et al. Driving and off-road impairments underlying failure on road testing in Parkinson’s disease. Mov Disord 2013; 28: 1949-1956
• 27 Amick MM, Grace J, Ott BR. Visual and cognitive predictors of driving safety in Parkinson’s disease patients. Arch Clin Neuropsychol 2007; 22: 957-967
• 28 Archibald NK, Clarke MP, Mosimann UP. et al. Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord 2011; 26: 2387-2395
• 29 Uc EY, Rizzo M, Anderson SW. et al. Impaired visual search in drivers with Parkinson’s disease. Ann Neurol 2006; 60: 407-413
• 30 Archibald NK, Hutton SB, Clarke MP. et al. Visual exploration in Parkinson’s disease and Parkinson’s disease dementia. Brain 2013; 136: 739-750
• 31 Chaudhuri KR, Prieto-Jurcynska C, Naidu Y. et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010; 25: 704-709
• 32 Uitti RJ. Parkinson’s disease and issues related to driving. Parkinsonism Relat Disord 2009; 15 (Suppl. 03) 122-125
• 33 Crucian GP, Armaghani S, Armaghani A. et al. Visual-spatial disembedding in Parkinson’s disease. J Clin Exp Neuropsychol 2010; 32: 190-200
• 34 Uc EY, Rizzo M, Johnson AM. et al. Real-life driving outcomes in Parkinson disease. Neurology 2011; 76: 1894-1902
• 35 Madeley P, Hulley JL, Wildgust H. et al. Parkinson’s disease and driving ability. J Neurol Neurosurg Psychiatry 1990; 53: 580-582
• 36 Lings S, Dupont E. Driving with Parkinson’s disease. A controlled laboratory investigation. Acta Neurol Scand 1992; 86: 33-39
• 37 Zesiewicz TA, Cimino CR, Malek AR. et al. Driving safety in Parkinson’s disease. Neurology 2002; 59: 1787-1788
• 38 Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102
• 39 Ondo WG, Dat VK, Khan H. et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 2001; 57: 1392-1396
• 40 Paus S, Brecht HM, Koster J. et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 2003; 18: 659-667
• 41 Weintraub D, Koester J, Potenza MN. et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595
• 42 Avanzi M, Baratti M, Cabrini S. et al. The thrill of reckless driving in patients with Parkinson’s disease: an additional behavioural phenomenon in dopamine dysregulation syndrome?. Parkinsonism Relat Disord 2008; 14: 257-258
• 43 Parsons TD, Rogers SA, Braaten AJ. et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588
• 44 Witt K, Daniels C, Reiff J. et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-614
• 45 Cavanagh JF, Wiecki TV, Cohen MX. et al. Subthalamic nucleus stimulation reverses mediofrontal influence over decision threshold. Nat Neurosci 2011; 14: 1462-1467
• 46 Frank MJ, Samanta J, Moustafa AA. et al. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007; 318: 1309-1312
• 47 Buhmann C, Maintz L, Hierling J. et al. Effect of subthalamic nucleus deep brain stimulation on driving in Parkinson disease. Neurology 2014; 82: 32-40
• 48 Buhmann C, Gerloff C. Could deep brain stimulation help with driving for patients with Parkinson’s?. Expert Rev Med Devices 2014; 11: 427-429
• 49 Buhmann C, Oelsner H, Vesper J. Neurologische Leitlinie „Tiefe Hirnstimulation (THS) und Autofahren bei Morbus Parkinson“ der Arbeitsgemeinschaft Tiefe Hirnstimulation e.V. 2017
• 50 Schubert W, Schneider W, Eisenmenger W. et al. Begutachtungsleitlinien zur Kraftfahrereignung – Kommentar. 2. Aufl. Bonn: Kirschbaum; 2005
• 51 Fründt O, Fadhel M, Heesen C. et al. Do impulse control disorders impair car driving performance in patients with Parkinson’s disease? submitted.
• 52 Buhmann C, Vesper J, Oelsner H. Fahreignung bei Morbus Parkinson: Driving ability in Parkinson’s disease. Fortschr Neurol Psych 2018; 86: 43-48
• 53 Classen S, Witter DP, Lanford DN. et al. Usefulness of screening tools for predicting driving performance in people with Parkinson’s disease. Am J Occup Ther 2011; 65: 579-588
• 54 Lachenmayer L. Parkinson’s disease and the ability to drive. J Neurol 2000; 247 (Suppl. 04) IV/28-IV/30